Re: Scholten et al. Nuclear β‐catenin is a molecular feature of type I endometrial carcinoma. J Pathol 2003; 201: 460–465
- 20 February 2004
- journal article
- letter
- Published by Wiley in The Journal of Pathology
- Vol. 202 (4) , 511-512
- https://doi.org/10.1002/path.1540
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Nuclear β‐catenin is a molecular feature of type I endometrial carcinomaThe Journal of Pathology, 2003
- β‐Catenin mutations in pulmonary blastomas: association with morule formationThe Journal of Pathology, 2003
- Abnormalities of E‐ and P‐cadherin and catenin (β‐, γ‐catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasiaThe Journal of Pathology, 2003
- Cribriform‐morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the β‐catenin geneThe Journal of Pathology, 2002
- Abnormalities of the APC/β-catenin pathway in endometrial cancerOncogene, 2002
- CTNNB1 mutations and β-catenin expression in endometrial carcinomasHuman Pathology, 2002
- Frequent nuclear ?-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiationThe Journal of Pathology, 2001
- β- And γ-catenin expression in endometrial carcinoma. Relationship with clinicopathological features and microsatellite instabilityVirchows Archiv, 2001
- β- Catenin mutations and aberrant nuclear expression during endometrial tumorigenesisBritish Journal of Cancer, 2001
- β-Catenin Expression Pattern in Stage I and II Ovarian CarcinomasThe American Journal of Pathology, 1999